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Background: Immunocompromised patients, particularly after lung transplantation, are at high risk to develop
atypical forms of pulmonary infections including influenza A/H1N1. Acute Fibrinous and Organizing Pneumonia
(AFOP) is a special histological pattern in acute respiratory failure with high mortality.
Case presentation: We describe a 66-year-old woman with double lung transplantation in August 2009 due to
end stage pulmonary fibrosis. After prolonged weaning and subsequent promising course, she developed atypical
pneumonia with diffuse pulmonary infiltrates in both lungs in January 2010. Infection with influenza A/H1N1 virus
was verified. The patient rapidly suffered from respiratory insufficiency and died eight days after this diagnosis. The
post-mortem revealed especially in the lower parts of the lungs the classical histological pattern of pure AFOP.
Molecular analyses of lung tissue were positive for influenza A/H1N1.
Conclusion: To our knowledge we present the first case of AFOP triggered by viral infection, here proven to be
influenza virus A/H1N1. Thus, also in the setting of viral infection the highly deadly differential diagnosis of AFOP
must be considered.
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Immunocompromised patients, especially after lung trans-
plantation are at high risk to develop atypical pneumonias.
Among viral infections, influenza A/H1N1 pneumonia
can lead to severe respiratory conditions in this patient
group often resulting in deadly respiratory insufficiency.
Acute fibrinous and organizing pneumonia (AFOP) is a
distinct reaction pattern in acute respiratory failure with
high mortality rate of upto 90%. Although some causes of
AFOP are known so far, its pure form without the pres-
ence of accompanying hyaline membranes typical for dif-
fuse alveolar damage (DAD) has not been described to be
linked to viral pneumonias.* Correspondence: gian.kayser@uniklinik-freiburg.de
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Clinical course
The 66-year old caucasian female patient suffered from
end-stage pulmonary fibrosis caused by usual interstitial
pneumonia (UIP) first diagnosed in November 2004.
According to the guidelines of the International Society
for Heart and Lung Transplantation, the patient was sub-
mitted to double sided lung transplantation in August
2009. Immediate post-operative course was complicated
by prolonged respiratory weaning with the necessity of
percutaneous tracheotomy. The patient could not be im-
munized with influenza vaccination due to poor general
condition in September and October 2009, the vaccination
period for the seasonally expected influenza viruses. In
November 2009, the patient was transferred to rehabilita-
tion treatment. During the end of December 2009 and the
beginning of January 2010, she complained about persis-
tent cough. Because of aggravation of her general and es-
pecially respiratory condition, she was admitted to a locald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Timeline of the clinical course
Date Clinical course Therapy
November 2004 Diagnosis of usual interstitial pneumonia (UIP)
August 2009 Double lung transplantation,
complicated postoperative course
November 2009 Rehabilitation treatment
December 2009 -
January 2010
Persistent cough Admission to general hospital
3.1.2010 Aggravation of general/ respiratory condition Admission to intensive care unit
Respiratory insufficiency Intubation
5.1.2010 Nasotracheal secretion positive for viral influenza A/H1N1 RNA (working diagnosis:
H1N1 pneumonia with bacterial superinfection)
Meropenem, clarithromycin and
oseltamivir
7.1.2010 Detection of viral influenza A/H1N1 RNA by real-time PCR (bronchoscopy)
Detection of mutation causing resistence against oseltamivir Switch from oseltamivir to zanamivir
Acute renal failure Continuous venous-venous
hemofiltration
8.1.2010 Respiratory insufficiency Extracorporeal interventional lung assist
implantation
11.1.2010 Rapidly progressive respiratory failure Death
a
b
Figure 1 Radiographic findings: computer tomography shows
bronchiectasis and consolidation especially in the right lower
lobe (a) and increasing bilateral diffuse pulmonary infiltrates in
both lungs with ground glass opacities seen in chest x-ray (b).
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sequent intubation was needed. High-dose corticosteroid
therapy was initiated to overcome acute organ rejection.
As respiratory insufficiency further deteriorated, she was
finally transferred to the intensive care unit of the medical
department at the University Medical Center Freiburg.
Nasotracheal secretion was positive for viral influenza
A/H1N1 RNA, proved by RT-PCR. Under the working
diagnosis of influenza A/H1N1 pneumonia with bacterial
superinfection, therapy with meropenem, clarithromycin
and oseltamivir was initiated. Because a mutation caus-
ing resistance against Oseltamivir was detected.in further
PCR work-up, oseltamivir was subsequently switched to
zanamivir. Immunosuppressive therapy was continued
with prednisolone and mycophenolate-mofetil, while ta-
crolimus was interrupted due to high serum levels.
Because of acute renal failure and suspected heparin-
induced thrombocytopenia type II, continuous venous-
venous hemofiltration was initiated. Despite extracorporeal
interventional lung assist implantation, sufficient carbon
dioxide elimination could not be reached and the patient
died due to rapidly progressive respiratory failure four days
after the diagnosis of influenza A/H1N1 infection of the
lung (timeline of the clinical course see Table 1).
Bronchoscopy
After admission to the medical intensive care unit, bron-
choscopy was performed to evaluate initial differential
diagnoses of acute graft rejection and infectious pneu-
monia. Bronchial mucosa was edematous and reddened.
Mucus was viscous but not extensive in amount. Surgi-
cal anastomoses were inconspicuous. No pus or signs of
acute bacterial infection could be observed. Bronchio-
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microbiological examination.
Imaging
Chest radiography revealed increasing bilateral diffuse
pulmonary infiltrates in both lungs with ground glass
opacities. Additionally, bronchiectasis and consolidation
in the right lower lobe were noticed (Figure 1).
Infectious workup
In sputum and BAL samples, infection with influenza
virus A/H1N1 could be verified four days prior to death
by real-time RT-PCR [1]. Multiplex-PCR proved to be
negative for other bacterial or viral infections. Accord-
ingly, cytomegalovirus PCR, cell culture assays and bac-
terial and fungal cultures were negative during her last
hospitalisation period at the University Medical Center
Freiburg.
Post mortem
Thoracic situs with status post double sided lung trans-
plantation was evident with sufficient anastomoses of
the transplanted organs. The lungs were consolidated in
consistency but patchy discolorization typical fora
c
Figure 2 Postmortem histological findings in the lungs. a-c) AFOP: pat
intraalveolar fibrin deposits (so called fibrin balls) and formation of fresh fib
absent (10×; H&E, PAS and EvG staining); d) unaffected lung parenchyma obacterial pneumonic infections were not present. Espe-
cially the lower parts of the lungs showed classical micro-
scopic features of AFOP with distinct patchy intraalveolar
formation of fibrin balls, focal fibroblast foci and diffuse
organizing pneumonia (Figure 2). Hyaline membranes
were not detected in any histological specimens. Thus,
pure AFOP not associated with other histological patterns
of DAD was verified. No signs of graft rejection, bacterial
or fungal superinfections or a relapse of UIP were seen.
Molecular analysis of lung tissue revealed positive
results for influenza A/H1N1by PCR. There was no
detection of any bacterial or fungal infection in any
analysed lung specimen, neither by microbiological nor
by histological examination.Discussion
Epidemic influenza A/H1N1 originally developed in the
United States of America and Mexico in 2009 and finally
spread worldwide to a pandemic disease [2,3]. The first
case in Germany was registered in April 2009 [4]. Influenza
virus infections may cause serious pulmonary complica-
tions with death rates of approximately 7% [5,6]. Although
previously healthy patients may suffer from severe H1N1b
d
chy involvment of lung parenchyma of the lower lobe with cubic
roblast foci as sing for organizing pneumonia, hyaline membranes are
f the upper lobe (10×; H&E staining).
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tients with predisposing conditions, i.e. obesity, pulmonary
diseases, other than asthma or chronic obstructive pul-
monary disease, pregnancy or pneumonia [6].
Patients with primary or secondary immunodeficiencies,
particularly patients after lung transplantation are at espe-
cially high risk for development of severe pulmonary com-
plications caused by influenza A/H1N1 infections. This,
therefore, demonstrates a severe condition in lung trans-
planted patients [2,5,7].
AFOP was first described by Beasley et al. [8] in 2002
and represents a distinct histological pattern of lung in-
jury related to DAD. Beasley described two forms of
AFOP: one less aggressive with good response to corti-
costeroids, the other with poor clinical outcome and a
high mortality rate of 53% [8]. AFOP presents with spe-
cific histological features, i.e. patchy intraalveolar fibrin
deposits, diffuse organizing pneumonia and absence of
hyaline membranes. In the current literature, causes of
AFOP are idiopathic or in combination with collagen
vascular diseases [9], bacterial infections [10] and af-
ter certain drug exposure (e.g. amiodarone, abacavir
[8,11], statins [12] as well as exposure to inhalative
agents (e.g. coal mining, construction, zoological work,
hairspray) [8].
One of a newborn child is reported with acute respira-
tory distress syndrome and AFOP after respiratory syncy-
tial virus pneumonitis [13]. However, histology revealed
hyaline membranes in the vicinity of AFOP-patterns, thus
classifying it as DAD with focal patterns of AFOP. In con-
trast, upon autopsy of our patient no hyaline membranes
were detected in any tissue sample. Therefore, in the case
presented here, pure AFOP in association with viral infec-
tion is to be diagnosed.Conclusion
Concluding, for the first time proof is given that viral
agents at least of the myxovirus family - here influenza
A/H1N1 - can induce pure often fatal AFOP. Conse-
quently, AFOP in the setting of viral pneumonia must
be taken into account especially in immunocomprom-
ised patients as successful treatment with a combination
of corticosteroids and mycophenolate-mofetil has re-
cently been reported [14].Consent
Informed and written consent for post-mortem in-
vestigation, scientific research and following publica-
tion as clinical image was given by the patient prior
to death.
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